General Information of Drug Inactive Ingredient (DIG) (ID: E00394)

DIG Name
Dextrose anhydrous
Synonyms
D(+)-Glucose; 50-99-7; (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal; aldehydo-D-glucose; Dextrose Anhydrous; D-Glucose In Linear Form; Anhydrous dextrose; Glucose, anhydrous; Dextrose, anhydrous; D-Glucose, anhydrous; UNII-5SL0G7R0OK; 5SL0G7R0OK; Sirup; Glucose liquid; anhydrous dextrose (open form); Sugar, grape; CHEBI:42758; Dextrose (polymer); Polyglucose; Glucose Polymer; Dextrose (D-Glucose) Anhydrous; DL-Glucose; Glucans; Glucopur; Maxijul; Synthetic glucan; Poly-D-glucose; 58367-01-4; D-Glucose polymer; Glucose homopolymer; GLO; D-Glucose, polymers; (14C)-Glucose; (14C)D-Glucose; (C13)D-Glucose; (U-14C)Glucose; 28823-03-2; D-Glucose, homopolymer; Glucose (C-13); Glucose (C-14); D-(U-14C)Glucose; (U-13C)-D-glucose; D-Glucose, labeled with tritium; linear D-glucose; D(+)-Glucose, anhydrous, specificied according to the requirements of Ph.Eur., USP, BP; 25191-16-6; D-Glucose, labeled with carbon-13; D-Glucose, labeled with carbon-14; EINECS 200-075-1; Glucose [JAN]; NSC 83659; NSC 406891; BRN 1724615; D-Glucose - anhydrous; UREA-FORMALDEHYDERESIN; CHEMBL448805; Dextrosum (Glucosum) anhydricum; DTXSID4048729; DTXSID7022910; D-Glucose;Grape sugar;Glucopyranose; HY-B0389; 7531AF; ANW-31176; MFCD00148912; s2123; AKOS006239080; ZINC100009383; CCG-266428; DB01914; MP-2142; D(+)-Glucose, ACS reagent, anhydrous; NCGC00386163-02; 19030-38-7; 8027-56-3; 815-92-9; SW220288-1; D-(+)-Glucose, 1M aqueous solution, sterile; AB01274744-01; AB01274744_02; 4-01-00-04302 (Beilstein Handbook Reference); A828386; Q21036645; (2R,3S,4R,5R)-2,3,4,5,6-pentakis(oxidanyl)hexanal; 109427F7-ABCA-4F12-91AE-01BC27C22B31; UNII-ED959S6ACY component GZCGUPFRVQAUEE-SLPGGIOYSA-N; UNII-IY9XDZ35W2 component GZCGUPFRVQAUEE-SLPGGIOYSA-N; UNII-W8K377W98I component GZCGUPFRVQAUEE-SLPGGIOYSA-N; UNII-YUH1C99228 component GZCGUPFRVQAUEE-SLPGGIOYSA-N
DIG Function
Binding agent; Diluent; Flavoring agent; Tonicity agent
Formula
C6H12O6
Canonical SMILES
C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O
InChI
1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1
InChIKey
GZCGUPFRVQAUEE-SLPGGIOYSA-N
Physicochemical Properties Molecular Weight 180.16 Topological Polar Surface Area 118
XlogP -2.9 Complexity 138
Heavy Atom Count 12 Rotatable Bond Count 5
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 6

Full List of Drug(s) Co-administrated with This DIG

7 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Aspirin DM672AH Acute coronary syndrome [BA41] Aspirin 81 mg tablet F01681
Buprenorphine DMPRI8G Opioid dependence [6C43.2Z] Buprenorphine Hydrochloride eq 0.3mg base/ml injectable F23390
Esomeprazole DM7BN0X Cystic fibrosis [CA25] Esomeprazole 20 mg capsule F07502
Labetalol DMK8U72 Hypertension [BA00-BA04] Labetalol Hydrochloride 5mg/ml injectable F23470
Metoprolol DMOJ0V6 Acute coronary syndrome [BA41] Metoprolol Tartrate eq 50mg base/100ml injectable F23349
Stiripentol DMMSDOY Dravet syndrome [8A61.11] Stiripentol 250 mg powder F24373
Triamcinolone DM98IXF Acute adrenal insufficiency [] Triamcinolone 55ug spray F23919
------------------
⏷ Show the Full List of 7 Approved Drug(s)
1 Investigative Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Oxybutynine DMJPBAX Obsolete neurogenic bladder [] Oxybutynin 10 mg tablet F16164
------------------